CARDIOVASCULAR RISK ASSESSMENT WITH THE AMERICAN HEART ASSOCIATION CALCULATOR IN TYPE 2 DIABETES PATIENTS: A COMPARISON OF EMPAGLIFLOZIN INDICATIONS BASED ON AMERICAN AND EUROPEAN GUIDELINES IN SOUTHEAST OF IRAN IN 2023

Papers | 2025 | CARDIOVASCULAR RISK ASSESSMENT WITH THE AMERICAN HEART ASSOCIATION CALCULATOR IN TYPE 2 DIABETES PAT...

Papers

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

Article Name:

CARDIOVASCULAR RISK ASSESSMENT WITH THE AMERICAN HEART ASSOCIATION CALCULATOR IN TYPE 2 DIABETES PATIENTS: A COMPARISON OF EMPAGLIFLOZIN INDICATIONS BASED ON AMERICAN AND EUROPEAN GUIDELINES IN SOUTHEAST OF IRAN IN 2023

Writers:

Khoshnazar S.M., Shabanzadeh R., Yousefzadeh G.

Journal name:

Diabetes Mellitus

Year of publication:

2025

Magazine number:

28(2)

Related Links

Voting

What’s your opinion About New Website?

Weak

Normal

Good

Excellent

Weak

Normal

Good

Excellent

100%


	Physiology Research center, Institute of Neuropharmacology, Vice Chancellor for research and Technology, Ebnsina Ave.Jihad Bolvd.Kerman,Iran Postal Code: 7619813159
	Phone : 009834 32264071
	Fax : 009834 32264097
	Email: kerman.physiology@gmail.com , kprc@kmu.ac.ir

Today: 247

Total Hit: 176,651

Last Update: Tuesday, February 10, 2026

IP Address: 172.27.253.190